Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 254

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection

Open access
Krentz, HB, Auld, MC, Gill, MJ · 2004 · HIV Medicine

Abstract

Objective: To compare the direct costs of medical care in the year following HIV diagnosis for patients who present with a CD4 count<200 cells/μL (‘late presenters’) and those who present with a CD4 count >200 cells/μL (‘early presenters’). Methods: Direct costs (i.e. drugs, laboratory tests, outpatient care, in‐patient care, and home care) for the 12 months following HIV diagnosis, sociodemographic data and clinical data were collected for all patients presenting for HIV care in Southern Alberta, Canada between April 1996 and April 2001. Mean costs are presented as costs in 2001 Canadian dollars. Results: Thirty‐nine per cent of 241 patients presented with a CD4 count <200 cells/μL. The mean costs for late presenters were more than twice as high as those for early presenters (i.e. $18 448 vs. $8455, respectively). Late presenters were more likely to be older, male and black, and to have a risk activity of men having sex with men (MSM) or heterosexual contact (P<0.05). However, the large difference in mean costs cannot be attributed to differences in characteristics. When characteristics were statistically held constant, the estimated excess cost of late presentation was almost unaffected, at $9723 (z=5.6). Repeating the analysis using disaggregated costing categories suggested that the difference in total costs was largely attributable to differences in HIV‐related hospital care costs, which were 15 times higher for late presenters. Conclusions: Direct care costs in the year following HIV diagnosis were more than 200% higher for patients who presented late. This difference could not be attributed to differences in patient characteristics. Most costs were attributable to HIV‐related hospital care costs and the immediate initiation of antiretroviral therapy. While early diagnosis in those at risk for HIV remains medically important, the short‐term economic impact is also substantial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-1293.2004.00193.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 254

Metadata

Authors
Krentz, H., Auld, M., & Gill, M.
Venue
HIV Medicine
Publisher
Wiley
Published
2004-03
Volume
5
Issue
2
Pages
93-98
ISSN
  • 1464-2662 (ISSN-L)
  • 1468-1293
OpenAlex
W1967410659
Cited by
254
References
13
FWCI
4.24
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection. https://app.cochat.ai/papers/10.1111/j.1468-1293.2004.00193.x
The paper
Krentz, H., Auld, M., & Gill, M. (2004). The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection. HIV Medicine. https://doi.org/10.1111/j.1468-1293.2004.00193.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.